The Street Is Finally Waking Up To Conmed Corp. (NYSE: CNMD)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed CONMED Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

Conmed Corp. is listed on the NYSE as a member of the Healthcare sector and is a part of the Medical Devices industry. The current market capitalization of Conmed Corp. is $2.67B. A total of 0.57 million shares were traded on the day, compared to an average of 1.18 shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, CNMD has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 39 BUYs and 40 SELLs from insiders. Insiders purchased 124,512 shares during that period but sold 126,026.

In the most recent transaction, Peters Stanley W III sold 2,300 shares of CNMD for 109.93 per share on Dec 04. After the transaction, the President AS and AET now owns 63 company shares. In a previous transaction on Nov 07, Peters Stanley W III sold 1,200 shares at 102.39 per share. CNMD shares that President AS and AET owns now total 63.

Among the insiders who sold shares, Peters Stanley W III disposed of 2,000 shares on Sep 13 at a per-share price of $107.31. This resulted in the President AS and AET holding 63 shares of CNMD after the transaction. In another insider transaction, Garner Todd W sold 1,355 shares at $112.00 per share on Aug 16. Company shares held by the Executive Vice President & CFO now total 0.

Dividend

It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. Conmed Corp. pays an annual dividend of $0.80 (0.92%), resulting in a dividend yield of 0.80 (0.92%), and it has a price to earnings (P/E) ratio of 42.61. CNMD’s most recent ex-dividend date was 12/15/2023 when it declared a $0.20 quarterly dividend that was paid in cash on 1/5/2024. Previously, the company paid the dividend on 10/5/2023 with an ex-dividend date of 9/14/2023. The CNMD stock dividend was $0.20 per share in cash.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for CNMD in the last 3 months, the mean price target is $111.13 with high estimates of $132.00 and low estimates of $98.00. In terms of 52-week highs and lows, CNMD has a high of $138.47 and a low of $80.01.

As of this writing, CNMD has an earnings estimate of $0.74 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of $0.74 per share and a lower estimate of $0.73. The company reported an EPS of $0.9 in the last quarter, which was 8.40% higher than expectations of $0.83.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CNMD’s latest balance sheet shows that the firm has $20.85M in Cash & Short Term Investments as of fiscal 2021. There were $684.66M in debt and $196.65M in liabilities at the time. Its Book Value Per Share was $25.90, while its Total Shareholder’s Equity was $785.43M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CNMD is Buy with a score of 4.00.

Most Popular

Related Posts